24
Participants
Start Date
October 15, 2025
Primary Completion Date
December 9, 2026
Study Completion Date
December 9, 2026
Ruxolitinib Cream
Ruxolitinib cream applied topically to the affected area as a thin film twice daily.
NOT_YET_RECRUITING
Equity Medical, Llc, New York
NOT_YET_RECRUITING
Paddington Testing Co Inc, Philadelphia
NOT_YET_RECRUITING
Lane Dermatology and Dermatologic Surgery, Columbus
RECRUITING
International Clinical Research Tennessee Llc, Sanford
RECRUITING
Lenus Research Medical Group, Llc, Sweetwater
RECRUITING
Trueblue Clinical Research, Tampa
NOT_YET_RECRUITING
Equity Medical, Llc, Bowling Green
NOT_YET_RECRUITING
Centricity Research Columbus Ohio Multispecialty Office, Columbus
NOT_YET_RECRUITING
Revival Research Institute, Llc Troy, Troy
RECRUITING
Red River Research Partners, Fargo
NOT_YET_RECRUITING
Red River Research Partners, Bolivar
RECRUITING
Delricht Research, Baton Rouge
RECRUITING
Unity Clinical Research, Oklahoma City
WITHDRAWN
Dermresearch, Inc., Austin
NOT_YET_RECRUITING
Clarity Dermatology, Castle Rock
NOT_YET_RECRUITING
Saguaro Dermatology, Phoenix
NOT_YET_RECRUITING
Clinical Trials Research Institute, Thousand Oaks
RECRUITING
Amicis Research Center Valencia, Northridge
NOT_YET_RECRUITING
First Oc Dermatology, Fountain Valley
NOT_YET_RECRUITING
Dr Bobby Buka, Md Greenwich Village, New York
Lead Sponsor
Incyte Corporation
INDUSTRY